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Metabolite of Scutellaria baicalensis 
 Chenggang Huang et al.* 
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 
China 
1. Introduction 
Rheum palmatum L., one of the commonly used Traditional Chinese Medicines (TCMs), 
which is called Dahuang in Chinese, has been successfully used in China for thousands of 
years. The crude material of R. palmatum called rhubarb was widely used as laxative to treat 
constipation. Furthermore, it has various other pharmacological actions, such as 
antibacterial [1, 2], anti-inflammatory [3, 4], antiviral [5], anti-angiogenic [6], antioxidative 
[7], immunomodulatory [8], protecting effects in rat with chronic renal failure [9] and anti-
diabetic effects on diabetic mice [10]. Although many investigations have been conducted in 
the fields of pharmacology, clinical trials, and phytochemistry about rhubarb, researchers 
still do not know what its effective constituents are, how many compounds are absorbed 
into blood after intragastric administration of the decoction, and what the fate of the 
decoction in the body is. The limited knowledge about the metabolism of rhubarb decoction 
restricts the deeper pharmacological mechanism study and wider clinical use of rhubarb. 
It was well accepted that TCMs expressed its effects through multi-components and multi-
targets. Rapid, sensitive and selective analytical method is needed to simultaneous 
determine of multiple components of TCMs in biological matrix with low concentrations. In 
recent years, HPLC/ESI/MSn has been proved to be a modern and powerful method for the 
identification of compounds in biosamples or TCM extracts [11, 12]. Metabolism of rhubarb 
has been reported [13], but data on pharmacokinetics are scanty. So, our interest was to 
utilize a solid phase extraction (SPE) and HPLC/ESI/MSn techniques for the detection of 
potentially active compounds in urine, plasma and tissue samples and for the 
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pharmacokinetic study of rhubarb. Total of 39 compounds were identified as absorbed 
bioactive constituents. The excretion of M22 and M39 reached more than 1000 μg in urine 
samples after intragastric administration of the decoction. 
2. Experiments 
2.1 Chemicals and materials 
Standards of the rhapontin, aloe-emodin, chrysophanol, emodin, rheochrysidin and rhein 
were obtained from the National Institute for the Control of Pharmaceutical and Biological 
Products (NICPBP) (Beijing, China). The plasma, urine and tissue samples were extracted 
using SupelcoTM LC-18 solid-phase extraction (SPE) tubes (1ml/100mg, USA). Acetonitrile 
(HPLC grade) was purchased from the Dikma Company (Dikma, USA). Water was 
deionized and double distilled. All other chemicals were of analytical grade. Blank rat 
plasma (drug free) was prepared in our laboratory. 
2.2 Equipment 
An HPLC-MS system (Agilent 1100, Agilent Technologies, Wilmington, DE, USA) with an 
electrospray ionization (ESI) ion source was used. The LC/MSD Trap software (version 5.3) 
was used for data acquisition and processing. An API 4000 triple quadrapole instrument 
(Applied Biosystems, Toronto, Canada) was used for the mass spectrometric detection using 
an electrospray ionization (ESI) source in the negative mode. A high-speed bench-top 
centrifuge (Sorvall ST16, Thermo Fisher Scientific, Germany) was used for centrifuge 
biological samples. 
2.3 Preparation of rhubarb decoction 
200 g rhubarb was immerged in 2000 mL distilled water and then refluxed for 1 h at 100ºC. 
The aqueous extract was filtered and the residue was refluxed for 30 min with another 2000 
mL of distilled water under the same conditions. The two water extracts were combined and 
condensed to 200 mL and stored at 4ºC until use. 
2.4 Standard preparation 
The standard of rhapontin, aloe-emodin, chrysophanol, emodin, rheochrysidin and rhein 
were dissolved in methanol at a concentration of 100 μg/ml to obtain the standard stock 
solutions. 
2.5 Animals 
30 male Sprague-Dawley rats (200±20 g) were obtained from the Animal Center of Shanghai 
Institute of Materia Medica, Shanghai, China. They were kept under standard laboratory 
conditions (12/12 h light/darkness, 22±2ºC room temperature, 50-60% humidity) for one 
week prior to the experiments. All animal experiments were carried out according to the 
Guidelines for the Care and Use of Laboratory Animals, and were approved by the Animal 
Ethics Committee of Shanghai Institute of Materia Medica. 
Six male rats were orally administered a single dose of rhubarb decoction at 10 g/kg. After 
dosing, the rats were housed in separate glass metabolic cages with free access to water. 
Urine was collected at -8 to 0 h predose and during 0-2, 2-4, 4-6, 6-8, 8-24, 24-36, 36-48 h 
postdose. 
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Other 24 male rats were divided into four groups at random. They were used in 
determining the concentration of rhubarb in blood and tissues. One group of rats was killed 
predose to provide control blood and tissues for analysis. Other three groups of rats were 
orally administrated of rhubarb decoction at a dosage of 17.6 g/kg. Six rats each were 
anesthetized with ether and blood samples were collected from abdominal aorta of the rats 
at 1.0, 2.0, and 3.0 h after dosing, respectively. The following tissues and organs were 
collected and weighed at the time of killing for determination of rhubarb concentration: 
heart (HE), liver (LV), spleen (SP), lung (LU), kidney (KI), brain (BR), small intestine (SI), 
large intestine (LI), stomach (ST), and testis (TE). The whole tissues were homogenized with 
PBS to yield final concentration of 20% w/v. All the homogenates were stored at -80ºC. 
2.6 Extraction of rat biological samples 
All samples were centrifuged at 3000×g for 10 min. The supernatants were loaded onto a 
C18 SPE cartridge. Before use, an SPE column was conditioned and washed with 2 ml of 
methanol and then 2 ml of deionized water. Then 600 μl of the selected supernatant sample 
was applied to the SPE well. The SPE well was washed with 1 ml of water, and then the 
analytes were eluted with 1 ml of methanol. The eluent was evaporated at 37ºC under a 
gentle stream of nitrogen. The dry residue was then reconstituted with 200 μl methanol and 
vortex-mixed for 20 s.  The solution was then centrifuged at 14000×g for 10 min, and an 
aliquot of 10 μl supernatant was injected into the HPLC/ESI/MS system for analysis. 
2.7 HPLC condition 
The metabolites of rhubarb decoction were separated on a Grace Apollo C18 reversed-phase 
column (250 mm×4.6 mm, 5 μm) equipped with an EasyGuard Kit C18 (4×2 mm) guard 
column. The column was maintained at 25ºC. The mobile phase consisted of 0.5% formic 
acid-water (A) and acetonitrile (B) and was delivered at a flow rate of 1.0 ml/min. The 
detection wavelengths were set at 190-400 nm. Gradient elution was used as follows: a linear 
gradient from 35% to 100% B in the first 30 min, followed by 100% B for 10 min, and finally a 
linear gradient to 35% B at 45 min that was held for 5 min. The total run time was 50 min. 
2.8 Mass spectrometry analysis for qualitation 
The HPLC system used was an Agilent 1100 series LC/MSD Trap mass spectrometer 
(Agilent Technologies, Wilmington, DE, USA), connected to an Agilent 1100 HPLC 
instrument via an electrospray ionization (ESI) source. The LC/MSD Trap software (version 
5.3) was used for system operation and data collection. The operating parameters in the 
negative ion mode were as follows: collision gas, ultra-high purity helium (He); nebulizing 
gas, high purity nitrogen (N2); capillary voltage, 3.5 kV; end plate offset, 500 V; nebulizer, 30 
psi; drying gas flow rate, 10 l/min; drying gas temp., 350ºC. Trap: ICC, target, 30000, max 
accu. time, 300.00ms, averages, 5. Auto Ms. 4; MS/MS frag. ampl., 1.00V; auto MS (n>2): 
frag. ampl., 0.77V. Smart frag: start ampl., 30.0%; end ampl., 200%. For full-scan MS analysis, 
the spectra were recorded in the range of m/z 50-1500. 
2.9 Mass spectrometry analysis for quantitation 
An API 4000 Qtrap mass spectrometer (Applied Biosystems, Toronto, Canada) equipped 
with a pneumatically assisted ESI interface was linked with the HPLC system. Initially 
optimization of the parameters for the ESI/MS and ESI/MS/MS analyses of the standards 
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and the samples was performed by direct infusion into the ES ionization source. The 
operating parameters were as follows: negative ion scan mode, curtain gas (CUR) 30 psi, 
collision gas (CAD) medium, ion source gas 1 (GC1) 45 psi, ion source gas 2 (GC2) 45 psi, 
ion spray voltage (IS) 5000 V, entrance potential (EP) 10 V, declustering potential (DP) 160 V, 
collision energy 60 V, collision cell exit potential (CXP) 3 V and temperature (TEM) 350ºC. 
3. Results 
3.1 Optimization of HPLC and MS conditions 
To obtain HPLC chromatograms with good separation and peak shape, different mobile 
phase compositions were screened. Given the acidity of phenolic compounds, it was found 
that acetonitrile and 0.5% aqueous formic acid were the most suitable eluting solvent 
system. The proposed method was acceptable as well as adequate for further MS/MS 
analysis. To acquire maximum sensitivity for most compounds, MS parameters such as 
spray voltage, capillary temperature, sheath gas and auxiliary gas pressure, source CID, 
collision gas pressure and collision energy were optimized using methanol extraction of 
rhubarb decoction by flow injection analysis (FIA). It was found that the negative ion mode 
was more sensitive than positive ion mode for most of the compounds. 
3.2 System suitability 
The system suitability test is performed to assure that the analytical method can be executed 
with the existing HPLC system. A system suitability test of the chromatographic system was 
performed before each validation run. Five replicate injections of a system 
suitability/calibration standard (at concentration of 10 μg/ml) were made. Area and 
retention time relative standard deviation, asymmetry factor ta and efficiency (as plate 
number N) for the five injections was determined. For all samples analyses, the asymmetry 
factor ta was≤1.4, efficiency≥3000 and area % R.S.D.≤1.0%. 
3.3 Optimization of sample preparation 
Solid-phase extraction was used as an important step of the sample preparation. 
Quantitative elution of standard samples from SPE cartridge are apparent after 1.0 ml of 
methanol. The reproducibility and recovery of solid-phase extraction was determined from 
five repetitions. The reproducibility expressed as R.S.D. was 0.6-0.9% and recovery was 84.8-
97.2% for concentration of 10 μg/ml of standard samples. 
3.4 Limits of detection (LOD)/ linearity/accuracy/precision for related substances 
The limit of detection of the six standard components (based on a detector signal-to-noise 
ratio 3:1) was 0.1 μg/ml. The method was found to be linear with correlation coefficients 
(R2) of 0.986-0.997 for the six standard components, with slops near unity and y-intercepts 
near zero for these low-level determinations. Accuracy and precision for the standard 
components were satisfactory at three concentrations studied. Accuracy and intra-day and 
inter-day precision of the six standard components were less than 10%. 
3.5 Stability of standard and sample solutions 
Prepared samples and standards have been shown to be stable for at least 2 weeks when 
stored refrigerated. Additionally, the standard solutions have been shown to be stable while 
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in use for assays for at least 72 h. The stability of the six standard sample solutions was 
evaluated after 1 and 2 weeks under refrigerated condition. The results obtained for 
refrigerated standard solution were 100.1 to 101.2% of the initial concentration for 1 and 2 
week time points, respectively. The result for the refrigerated sample solution were 102.1 to 
96.8% of its initial concentration after 1 and 2 week’s storage, respectively. No degradation 
products were observed for any of the solutions tested. The standard solutions that had 
been held at room temperature for 72 h were stable with responses of 98.7-100.9%. 
3.6 Fragmentation behavior of the parent compounds 
To interpret the mass spectra of the metabolites using the LC/MSn technique, it is necessary 
to fully understand the fragmentation behavior of the parent compound. Rhapontin, aloe-
emodin, chrysophanol, emodin, rheochrysidin and rhein were selected as representative 
parent compounds in this study. It was found that the negative ion mode was more 
sensitive than positive ion mode for most of the compounds with triple quadrupole mass 
spectrometer, so negative ion mode was chosen. The HPLC/ESI/MSn spectra of [M-H]- ion 
of the six parent compounds were shown in Fig.1. As most of these metabolites remained 
the structural features of the parent compounds, the analysis of the fragmentation pathways 
greatly facilitated the identification of metabolites from rhubarb decoction. 
 
 
Fig. 1. The HPLC/ESI/MS spectra of the parent compounds 
3.7 Identification of metabolites 
Possible metabolite structures were considered based on the parent structure and the known 
metabolic pathways. As for MS detection, the potential metabolites were detected by 
comparison of the chromatograms of the drug-containing samples with those of blank 
samples. The retention time of each potential metabolite was ascertained by employing its 
mass to generate its extracted ion chromatogram (EIC) of the drug-containing sample. 
Compared with blank samples, a total of 39 compounds were detected in extracted ion 
chromatograms from the drug-containing urine, plasma and tissue samples (Table 1). 
The identification of the metabolites and elucidation of their structures were performed 
mainly based on their MSn fragmentations. Possible metabolite structures were considered 
based on the parent structure and the known metabolic pathways. Then, rat urine, plasma 
and tissue samples after i.g. administration of rhubarb decoction were analyzed and 
compared with blank samples by HPLC/ESI/MSn in negative mode. Typical 
chromatograms resulting from the analysis of various biological samples are shown in Fig.2. 
Ultimately, the 39 metabolites could be generally divided into three groups: glucoside, 
glucuronidation and sulfation metabolites. The MS2 spectra of the 39 compounds were 
shown in Fig. 3. Metabolite M4, M10 and M20 were selected as examples and the structural 
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elucidations of the other metabolites were carried out similarly. The postulated 
fragmentation pathways of M4, M10 and M20 were shown in Fig.4. 
 
Metabolites 
t R 
(min) 
[M-H]- UR PL
Tissues ESI-MS data (% base peak) 
(m/z) HE LV SP LU KI BR SB LB ST TE
M1 3.3 591 + - - - - - - - - - - - 
MS2[591]:253(100),175(14.4) 
MS3[253]:253(100) 
M2 3.3 383 + - - - - - - - - - - - 
MS2[383]:303(34.7).207(100),113(52.1) 
MS3[207]:207(52.8),163(100),122(10.8) 
M3 3.3 445 - - - - - - - - - - + - 
MS2[445]:427(8.0),283(100),175(4.5) 
MS3[283]:283(100),239(17.4) 
M4 3.4 479 + - - - - - - - - - - - 
MS2[479]:303(100),174(20.9) 
MS3[303]:303(100),259(9.8) 
M5 3.4 417 + - - + - - - - - - - - 
MS2[417]:373(100),330(12.5),241(41.0),
175(3.7) 
MS3[373]:373(9.1),330(100) 
M6 3.5 313 + - - - - - - - - - - - 
MS2[313]:313(12.8),233(100),175(3.6) 
MS3[233]:233(100),189(11.2) 
M7 3.5 459 + + - - - - + - - - - - 
MS2[459]:283(100),175(3.6) 
MS3[283]:283(100),239(9.1) 
M8 3.7 475 - - - - - - - - - - + - 
MS2[475]:431(7.2),311(57.0),269(100) 
MS3[269]:269(100) 
M9 3.8 287 + - - - - - - - - - - - 
MS2[287]:287(8.3),207(100) 
MS3[207]:207(85.5),163(100) 
M10 4.1 621 - + - - - - - - - - - - 
MS2[621]:575(3.5),445(100),269(21.3) 
MS3[445]:311(7.8),269(100) 
M11 4.1 375 - - + - - - - - - - - - 
MS2[375]:332(18.8),243(100) 
MS3[243]:243(100) 
M12 4.2 445 + - - - - - - - - - - - 
MS2[445]:269(100),175(2.1) 
MS3[269]:269(100) 
M13 4.2 268 + - + - - - + - - - - - MS2[269]:189(100) 
M14 4.3 417 + + - - - - - - - - - - 
MS2[417]:399(8.1),241(5.1),175 (100) 
MS3[175]:113(100) 
M15 4.5 435 - - - - - - - - - - + - 
MS2[435]:273(100),167(4.3) 
MS3[273]:273(100),167(53.0) 
M16 4.6 431 - - - - - - - - - - + - 
MS2[431]:269(100) 
MS3[269]:269(100) 
M17 4.6 459 + - - - - - - - - - + - 
MS2[459]:283(100) 
MS3[283]:283(100),257(1.9) 
M18 4.7 297 + + + - - + + - - - - - 
MS2[297]:175(83.7),113(100) 
MS3[113]:95(80.0),85(100) 
M19 4.9 401 - + - + - + + - + - - - 
MS2[401]:358(100),296(4.2),225(32.4),
174(60.5) 
MS3[358]:313(13.5),174(100) 
M20 5.2 525 - + - - - - - - - - - - 
MS2[525]:445(100),349(20.3),269(73.5) 
MS3[445]:269(100) 
M21 5.3 349 + - - - - - - - - - - - 
MS2[349]:269(100) 
MS3[269]:269(100),240(5.8) 
M22 5.3 363 + - - - - - - - - - - - 
MS2[363]:283(100) 
MS3[283]:283(100),239(7.0) 
M23 5.4 433 - + - - - - - - - - - - 
MS2[433]:415(7.4),257(100),175(60.5) 
MS3[257]:257(100) 
M24 5.6 321 - + + + - - - - - + - - 
MS2[321]:241(100),121(87.7) 
MS3[241]:241(12.3),121(100) 
M25 6.0 473 - + - - - - - - - - - - 
MS2[473]:426(6.2),335(9.5),297(87.7),
253(100) 
MS3[253]:253(100) 
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M26 6.0 363 + + + - - - + - - - - - 
MS2[363]:283(100) 
MS3[283]:283(100),239(4.7) 
M27 6.3 407 - - - - - - - - - - + - 
MS2[407]:369(18.7),245(100) 
MS3[245]:245(100),230(50.4) 
M28 6.6 431 - - - - - - - - - - + - 
MS2[431]:340(3.3),269(100) 
MS3[269]:269(100) 
M29 6.6 429 + + - - - - + - - - - - 
MS2[429]:253(100),175(6.8) 
MS3[253]:253(100) 
M30 6.8 415 - - - - - - - - - - + - 
MS2[415]:253(100) 
MS3[253]:253(100) 
M31 7.0 429 + + + + - + + - - - - - 
MS2[429]:253(100),175(6.8) 
MS3[253]:253(100) 
M32 8.2 313 - - - - - - - - - - + - 
MS2[313]:269(100),201(5.4) 
MS3[269]:269(100) 
M33 8.4 445 + + + + - - + - - - - - 
MS2[445]:269(100) 
MS3[269]:269(100) 
M34 8.4 459 + - - - - - - - - - - - 
MS2[459]:283(100),175(7.0) 
MS3[283]:283(100) 
M35 10.2 443 - - - - - - - - - - - - 
MS2[443]:411(100),267(87.5),253(91.5),
157(10.9) 
MS3[411]:335(30.2),267(100),253(88.9) 
M36 11.5 297 + + + + - - + - + - + - 
MS2[297]:253(100) 
MS3[253]:253(100) 
M37 12.9 349 + - - - - - - - - - + - 
MS2[349]:269(100) 
MS3[269]:269(100) 
M38 14.3 561 + - - - - - - - - - - - 
MS2[561]:269(100),240(9.5) 
MS3[269]:269(100) 
M39 14.6 283 + + + + - + + - + - + + 
MS2[283]:257(100),239(66.9) 
MS3[257]:257(100),239(41.0) 
tR: retention time; +:found; -:not found; [M-H]: negatively charged molecular ion 
Table 1. The metabolites detected in rat urine, plasma and tissues after intragastric 
administration of rhubarb decoction 
M4, which was only detected in plasma samples produced a [M-H]- at m/z 479 with a 
retention time of 3.4 min. It was found that the [M-H-176]- ion plus the ion at m/z 303 were 
observed in its MS2 spectrum. So, M4 was identified as the metabolite that conjugated with 
one molecule of glucuronic acid (GlcA). The ion at m/z 303 could produce fragment ion at 
m/z 259. The spectroscope (MSn) data of M4 was different from those reported in the 
published literature before [14]. According to the data above, M4 was conjectured to be 
glucuronide conjugate of methyl catechin. 
M10 gave a [M-H]- signal at m/z 621 in the mass spectrum and fragmentation of the ion with 
the peak at m/z 621 gave the ion peak at m/z 445 (-176 Da), involving the loss of glucuronic 
acid. Then, the MS3 fragmentation yielded the ion peak at m/z 269 (-176 Da), involving 
another loss of glucuronic acid. The quasi-molecular ion of m/z 621 lost a 46 Da and a 30 Da 
fragmentation sequentially forming the product ions at m/z 575 and 591, suggesting that the 
mother nucleus was aloe-emodin, and the hydroxymethyl was not conjugated. Therefore, 
the compound M10 was identified as bisdesmoside conjugate of aloe-emodin. 
The mass spectrum of the compound M20 displayed a signal at m/z 525 ([M-H]-). A product 
ion spectrum of M20 displayed fragment ion at m/z 445, 400, 349 and 269. Fragmentation of 
the ion at m/z 525 gave the ion peak at m/z 349 (-176 Da), suggesting the loss of glucuronic 
acid. Meanwhile, fragmentation of the quasi-molecular ion yielded an ion peak at m/z 445 (-
80 Da), involving the presence of sulfate. Glucuronic acid group and sulfate were not 
conjuncted with hydroxymethyl of the parent compound, which was judged by sequential 
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loss of 44 Da and 46 Da. Therefore, the structure of M20 was conjectured to be glucuronide 
and sulfate conjugate of aloe-emodin, glucuronic acid group and sulfate occurred at the 1 
and 8-hydroxy, respectively. 
Based on the discussions above, the proposed metabolic pathways of rhubarb in rats are 
shown in Fig.5. The parent compound rhein was found in urine, plasma and most of the 
tissue samples. 
 
 
Fig. 2. Typical chromatograms of biological samples (a) chromatograms of urine samples 
after i.g. administration of 10 g/kg rhubarb decoction; (b) chromatograms of plasma 
samples after i.g. administration of 17.6 g/kg rhubarb decoction; (c) chromatograms of some 
tissue samples after i.g. administration of 17.6 g/kg rhubarb decoction 
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Fig. 3. The MS2 spectra of the 39 compounds 
 
 
 
Fig. 4. Postulated fragmentation pathways of the selected metabolites (a) M4; (b) M10; (c) M20 
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Fig. 5. The proposed transformation pathway of rhubarb in rats 
3.8 Urinary excretion of rhubarb 
The urinary excretion of rhubarb following a single intragastric administration of rhubarb 
decoction to rats is summarized in Fig.6. Among the 21 compounds detected in urine 
samples, the excretion of M22 and M39 were the largest, reaching more than 1000 μg in 48 h, 
the excretion of M5 and M26 has reached more than 500 μg. 
 
 
Fig. 6. Cumulative excretion curves of rhein (M39) and the metabolites of rhubarb following 
the intragastric administration of 10 g/kg rhubarb decoction to SD rats (a) the prototype 
component M39; (b) metabolites detected in urine samples 
3.9 Plasma concentration of rhubarb and the metabolites 
Among the 16 constituents detected in plasma, only rhein (M39) was the parent compound. 
The peak rhein concentration (Cmax) in plasma was 7.23 μg/ml. The peak concentration of 
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M19, a metabolite of emodin, reached 8.05 μg/ml at 2 h after i.g. administration of rhubarb 
decoction. The concentrations of the 16 compounds were shown in Table 2. 
 
Time 
(h) 
M7 M10 M14 M18 M19 M20 M23 M24 M25 M26 M29 M31 M33 M35 M36 M39 
1 2.55 0.72 1.76 6.53 4.14 0.33 1.02 1.11 0 4.01 3.40 1.34 3.90 0.80 3.56 7.23 
2 1.46 3.57 2.93 0 8.05 0.89 0.19 0.40 0.30 0 5.33 1.48 5.44 0 2.79 3.19 
3 0 4.07 1.40 1.18 5.53 0.65 0.11 0 0.35 0 3.89 1.64 0 0 0.62 1.27 
Table 2. The concentration of the 16 compounds detected in plasma (μg/ml) 
3.10 Tissue distribution of rhubarb 
Tissue distribution of the metabolites at 1.0, 2.0 and 3.0 h after a single intragastric 
administration of 10 g/kg rhubarb decoction to SD rats are also studied. Among the 24 
metabolites found, M36 and M39 were distributed in most of the tissues, tissue concentrations 
of M36 and M39 are shown in Fig.7. At 1.0 h after intragastric dosing, tissue concentrations in 
most tissues were higher than the corresponding concentrations at 2.0 and 3.0 h. M7, M13, 
M18, M26, M29 and M33 reached the highest amount of concentration in kidney, M3, M8, 
M15, M16, M17, M27, M28, M30 and M37 reached the highest amount in stomach at 1.0 h after 
intragastric dosing. A total of nine compounds were detected in heart samples, seven in liver 
samples, four in lung samples, ten in kidney samples, thirteen in stomach samples, one in 
large intestine samples, three in small intestine samples and one in testis samples. The 
metabolites detected were shown in Table 1. The highest level of most of the metabolites was 
observed in the stomach, while none of the metabolites was found in spleen and brain. 
 
 
Fig. 7. Distribution of (a) M36, (b) M39 at 1.0h, 2.0h and 3.0h following intragastric 
administration of 10 g/kg rhubarb decoction to SD rats. Each value represents mean and SD 
of six animals. 
4. Discussion 
Many medicinal herbs have a long history of clinical use. However, the safety and efficacy 
of most of these herbs in relation to their pharmacological activities are poorly understood. 
Furthermore, knowledge of the pharmacokinetics of the main bioactive ingredients of these 
herbs is extremely limited. Dahuang is one of the most commonly prescribed Chinese 
medicinal herbs for the treatment of constipation. However, pharmacokinetics of the main 
bioactive ingredients in this herb is largely unknown. 
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In this paper, we developed a triple quadruple MS method for analysis and identification 
the main bioactive components and their possible metabolites in urine, plasma and tissues. 
Following a single intragastric administration of rhubarb decoction to rats, 21 constituents in 
urine samples and 16 compounds in plasma samples were identified. Some constituents of 
rhubarb were rapidly absorbed into blood and tissues, indicating that the compounds might 
be responsible for curative effects of rhubarb decoction. Ten compounds were detected in 
kidney samples, it may elucidate that rhubarb decoction has the effects of anti-diabetic and 
protecting chronic renal failure in rats. [9, 10].Their conjugations of glucosides, glucuronide 
and sulfates were also detected and two of the parent compound aloe-emodin and rhein. 
The developed method was simple, reliable and sensitive, which revealed that it will be 
appropriate for rapid analysis and identification the characterization of main bioactive 
components and their metabolites in biosamples. However, the present study still 
demonstrated the analytical potential of this approach for identification of metabolites. This 
identification and structure elucidation of these metabolites provided essential data for 
further pharmacological and clinical studies of rhubarb and related preparation. 
5. Introduction 
The root of Scutellaria baicalensis, called Huangqin in Chinese, is one of the most commonly 
used traditional Chinese medicines for the treatment of hepatitis, tumors, diarrhea, and 
inflammatory diseases [15]. It originated from Shennong Materia Medica, the earliest 
pharmacopoeia of China in Eastern Han (24-220 A.D.), and has been officially listed in the 
Chinese Pharmacopoeia for a long time. The major chemical constituents of Huangqin are 
flavonoids. Modern pharmacological studies have demonstrated that flavones have wide 
biological activities, such as anti-oxidants, anti-cancer, anti-inflammatory, etc [16,17,18]. Few 
data are available on the metabolism and metabolites of S. baicalensis extract in vivo. 
Therefore it is important to explicate the biotransformation of flavonoids in vivo so as to 
clarify the mechanism of pharmacological action and to promote its availability as well. 
A simple and rapid high-performance liquid chromatographic-electrospray ionization (ESI) 
tandem mass spectrometric method has been developed for elucidation of the structures of 
the metabolites in rat plama, urine samples. LC-MS/MS is a more powerful analytical tool 
for the identification of durg metabolites in biological matrices by comparing changes in 
molecular masses (ΔM), retention-times, and spectral patterns of product ions with those of 
the parent drug [19,20]. 
6. Experimental  
6.1 Chemicals and reagents 
The roots of Scutellaria baicalensis Georgi were collected from Xi’an, ShanXi province, China, 
and authenticated by Professor Shen Jingui of Shanghai Institute of Materia Medica, Chinese 
Academy of Sciences. HPLC grade acetonitrile was purchased from Dikma Company (Dikma, 
USA). Water was deionized and double distilled. Other reagents used are of analytical grade. 
6.2 Instrumentation  
HPLC-MS experiments were performed with a Finnigan LCQ Advantage ion trap mass 
spectrometer (Thermo Finnigan, San Jose, CA) was connected to a Agilent 1100 HPLC 
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instrument via an ESI source. The software Xcalibur version 1.2 (Finnigan) was applied for 
system operation and data collection. A high-speed desktop centrifuge (TGL-16C, Shanghai 
Anting Scientific Instrument Factory, Shanghai, China) was used to centrifuge urine, plasma 
sample. The urine, plasma sample were extracted on a C18 solid-phase extraction (SPE) 
cartridge (1ml/100mg, Supelco). 
6.3 Chromatographic and mass spectrometric conditions 
An Agilent series 1100 HPLC instrument (Agilent, Waldbronn, Germany) equipped with a 
quaternary pump, a UV detector, and a column compatment was used for analyses. The 
samples were separated on a Apollo C18 column (5μm, 4.6 × 250mm, Grace), including an 
EasyGuad Kit C18 (4 × 2mm) guard column. The column was maintained at 25ºC. Detection 
wavelengths were set at 280nm. The flow rate was 0.8m/min. A gradient elution of 0.5% 
aqueous formic acid (A) and acetonitrile (B) was used as follows: 20% B in the first 10min, 
20%~25% B at 10~11 min, then B held at 25%  for 14min, linearly gradient to 35% B at 26 min 
and hold for 15min, 35%~55% B at 41~45 min, linearly gradient to 100%B at 50min and hold 
for 5min. The mass spectra were recorded in negative modes, drying gas flow rate 10L/min, 
drying gas temperature 35ºC, nebulizer 35 psig., capillary voltage 4000V, fragmentor 100V, 
mass range 50-1500 m/z. 
6.4 Administration 
Male Sprague-Dawley (SD) rats (220 ± 10g body weigh, laboratory Animal Center of 
Shanghai University of Tradition Chinese Medicine) were divided into a blank group and 
drug group. Prior to oral administration, each rat was fasted for 24h in a metabolic cage 
with free access to water, and were then administered 1.2g/Kg the extract of S. baicalensis by 
i.g. Urine were collected separately at 2h, 4h, 6h, 8h, 10h and 24h. Samples were stored at -
20ºC until analysis. Blood samples were collected at 0.25, 0.5, 1, 3, 5, 7, and 24h after dosing 
from the caudal vein of the rats, then shaken and centrifuged at 4000rpm for 10min. The 
supernatant was decanted, and immediately frozen at -20ºC until analysis.  
6.5 Sample preparation 
Solid phase extraction (SPE) with C18 cartridge (1ml/100mg, SupelcleanTM, Dikma) was 
used to purify the above supernatants of urine, plasma samples, for LC-MS/MS analysis. 
Before use, SPE columns were conditioned by 4ml methanol, 2ml deionized water. Then the 
selected supernatant sample was loaded, and the column was washed with 3ml deionized 
water to elute the impurity and 1ml methanol to elute the analytes in turn. The eluent was 
evaporated to dryness at 37ºC in vacuum, and the residue dissolved in 100μl of 100% 
methanol. After centrifugation at 8000rpm. for 10min, 10μl of the supernatant was 
introduced into the HPLC system for HPLC-MS. 
7. Results and discussion 
7.1 Identification of metabolites  
To elucidate the active constituents responsible for the pharmacological action, it is 
necessary to perceive the metabolic changes in vivo and chemical constituent profile in 
biological system. Therefore, the full-scan mass spectrum total-ion current chromatogram 
obtained from rat urine and plasma (Figs. 8(c), 9(b)) after i.g. of extract of S. baicalensis was 
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compared with that from blank urine to find probable metabolites. The results show that the 
total peaks and corresponding peak areas in metabolic chromatograms were different when 
collected at different periods, and the most abundant metabolites were found at 4-6h in 
urine samples. These compounds were then analyzed by LC-MS/MS. Using negative ion 
electrospray tandem mass spectrometry, a total of 12 and 6 metabolites were detected in 
drug-containing urine and plasma samples in comparison with the extract of S. baicalensis 
and blank sample.  
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Fig. 8. HPLC-MS total ion current of the S. baicalensis decoction and its metabolites in 
negative mode. (a) The decoction of S. baicalensis; (b) Blank rat urine; (c) Urine sample after 
oral administration. 
Peak 4 and 5 , 6 were confirmed as original components, baicalin (4) , wogonoside (5) and 
baicalein (6). The [M-H]- ion of baicalein at m/z 269 produced an ion at m/z 251, which 
should result from the loss of H2O. The ion at m/z 241 was due to the loss of CO, and the 
m/z 223 ion was due to the successive loss of H2O and CO. 
Peak 6 showed [M-H]- m/z 445.3, with retention a Baicalin is an O-glucuronide. Upon CID, 
the glycosidic bond was easily cleaved to generate an ion at m/z 269, which resulted from 
the neutral loss of a glucuronic acid (Δm = 176u). In the MS3 experiment, ion at m/z 269 
produced the same ions as baicalein described above. 
Wogonin is a methoxylated flavone. It exhibited a significant radical anion [M-H-CH3]− as 
the base peak. In MS3 spectra, we observed the significant ion at m/z 239 [M-H-CH3− -
COH]−, and the low signal intensity ions at m/z 163 (0,2A-), 212 [M-H-CH3-2CO]−, 223 [M-
H-CH3-CO2H]-, 240 [M-H-CH3-CO]-, which is identical with the previous report. 
Peak 7 showed a [M-H]- m/z 607.4, with retention time at 18.3min on HPLC. Its MS2 
produced an ion at m/z 431 [M-H-176]-, indicating the existence of a glucuronic acid. 
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Additionally, the successive yielded the ion at m/z 269 [M-H-176-162]-. Based on these data 
and by the knowledge on the flavones in S. baicalensis, compounds 1 were identified as 
Baicalein glucoside glucuronide conjugate. 
Peak 8 gave a [M-H]- ion at m/z 621.4, with retention time at 18.5min on HPLC. CID of this 
compound produced an ion of [M-H-176]- at m/z 445, which resulted from the neutral loss 
of a glucuronic acid residue. In the MS3 of m/z 445, fragments of m/z 430 and 269 indicated 
the presence of a H2O and a glucuronic acid, respectively. Therefore, this compound was 
thus proposed as Baicalin glucuronide conjugate. 
With a retention time at 19.6min on HPLC, peak 9 generated a [M-H]- at m/z 635.3 in MS 
spectrum and a [M-H]- at m/z 459 ([M-H]- -176, loss of a glucuronic acid) in MS2. In the MS3 
experiment, ion at m/z 283 produced the same ions as wogonoside described above. 
Therefore, compound 9 was thus proposed as Wogonoside glucuronide conjugate. 
Peak 10 displayed a [M-H]- ion at m/z 577.4, with retention time at 20.6min on HPLC. The 
MS2 and MS3 spectra gave ions at m/z 401 and 269, suggesting sequential losses of 
glucuronic acid (176 Da) and arabinose (132 Da) residues, respectively. This compound was 
thus identified as Baicalein xyloside glucuronide conjugate.  
Peak 11 showed a [M−H]− ion at m/z 417.3, with retention time at 21.4min on HPLC. In the 
MS2 speetrum of m/z 417.3, the fragment ion of 241 and 399 was generated by natural loss 
of a glucuronic acid and a H2O, then the successive yielded the ion at m/z 199 [M-H-GlcA-
C2H2O]− in MS3. Therefore, it was tentatively identified as pinosylvin 2-hydroxymethyl 
glucuronide conjugate. 
Peaks 12 and 15 are sulfation metabolites. Peak 12 with a retention at 23.6 min on HPLC, 
showed a [M−H]− m/z 539.4. In the MS2 speetrum, the fragment ion of 363 and 459, 
indicating loss of a glucuronic acid and SO3, respectively. Based on these data and by the 
knowledge on the flavones in S. baicalensis, this compound were identified as wongonoside 
sulfate conjugate. Peak 16 with a retention time at 33.7min on HPLC, yield MS fragments at 
m/z 363.2 and [M-H]- m/z 282.9 ([M-H]- - 80 Da, loss of a SO3) in MS2. Based on these data 
and by the knowledge on the flavones in S. baicalensis, this compound could be confirmed as 
wogonin sulfate conjugate. 
Peak 13 gave a [M-H]- ion at m/z 447.3, with retention time at 31.3min on HPLC. CID of this 
compound produced an ion of [M-H-176]- at m/z 270.9, which resulted from the neutral loss 
of a glucuronic acid residue. Based on these data and by the knowledge on the flavones in S. 
baicalensis, this compound was thus proposed as baicalein glucuronide conjugate.  
Peak 14, appearing at 31.8min on HPLC , had a [M-H]- at m/z 446 and yield a major ion at 
m/z 268.9 ([M-H]- - 176 Da, loss of a glucuronic acid unit) in MS2 and a MS3 fragment [M-H]- 
at m/z 251.0 ([M-H]- -176 Da–18 Da, loss of a glucuronic acid unit and one molecule of H2O). 
Therefore it was presumed as apigenin glucuronide conjugate, which acts as one of the 
major apigenin metabolites in urine. 
7.2 Plasma metabolites 
The direct comparison of the TIC chromatograms of the blank rat plasma and the rat plasma 
samples collected at 0.5, 1, 2, 3, 4h after the oral administration of the extract of S. baicalensis. 
It showed that the information in the chromatogram at 1h post administration was more 
sufficient (Fig.9(b)). Including two original components, two metabolites, were tentatively 
elucidated as baicalin glucuronide conjugate (16), baicalin (4), norwogonoside glucuronide 
conjugate (17), wogonoside sulfate conjugate (18), wogonoside (5).  
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Peak 17 with retention time at 33.7min on HPLC, showed a [M-H]- ion of m/z 621.1. The 
MS2 and MS3 spectra gave ions at m/z 445 and 269, suggesting sequential losses of two 
glucuronic acid (2 ×176 Da) residues. In the MS3 experiment, ion at m/z 225 produced [M-
2Glc A-CO-H]-. Base on these data, the structrue of 17 could be identified as norwogonoside 
glucuronide conjugate. 
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Fig. 9. HPLC-MS total ion current of the S. baicalensis decoction and its metabolites in 
negative mode. (a) Blank rat plasma; (b) Plasma sample after oral administration. 
7.3 Identification of Baicalin metabolites in rat blood 
Some reported that baicalin are the main active components of S. baicalensis [21]. In order to 
further study of baicalin metabolism in vivo. The metabolites of baicalin were studied further 
in rat plasma. 
We identified three metabolites and the parent drug in rat plasma after administration of 
baicalin by healthy rats. Their protonated molecular ions ([M-H]-) were at m/z 621, 643, and 
564, respectively. MSn spectra of motabolites, obtained by CID of their molecular ions, were 
used for more precise structural identification of metabolites. Among them, the retention 
time, the MS2 and MS3 spectra of the molecular ion at m/z 445 (M0) were the same as those 
of baicalin. Therefore, M0 is the unchanged parent drug.  
M1 was observed at the retention time of 19.9 min and gave an deprotonated molecule [M-
H]- at m/z 621. The ion at m/z 621 was increased by 176Da compared to that of unchanged 
baicalin and glucuronidation was a very common metabolic pathway of drug in vivo, 
indicating that M1 might be a conjugate of baicalin with glucuronic acid, which was 
confirmed by the characteristic fragment ions presented in the following MSn spectrum. The 
[M-H]- ion at m/z 621 of M1 generated the base peak at m/z 445 in the MS/MS spectrum, 
attributed to the loss of 176 Da, suggesting the loss of a glucuronic acid. Then the product 
ion at m/z 445 was subjected to MS3 analysis and produced an intense ion at m/z 268 by 
loss of a glucuronic acid group (176Da) again. Therefore, M1 was elucidated as baicalin 
glucuronide conjugate. 
M2, eluted at 20.1 min, exhibited [M-H]- signal at m/z 643 which was 198 Da greater than 
that of parent compound, which indicated that M2 was a Na glucuronide metabolite of 
baicalin. The MS2 spectrum of m/z 643 produced a significant radical ion at m/z 467 (Fig.10) 
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via the loss of glucuronic acid (176Da). Then the ion at m/z 467 was successively subjected 
to MS3 analysis and produced ion at m/z 269 by the loss of Na and glucuronic acid (198 Da). 
At the same time, the bask peak at m/z 241 was observed in the MS4 spectrum by the loss of 
CO (28Da) from the ion at m/z 269. Therefore, M2 was tentatively proposed to be the 
baicalin Na glucuronide conjugate. 
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Fig. 10. Negative ion ESI-MSn spectra of baicalin metabolites in rat plasma 
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M3 was detected as a deprotonated molecule [M-H]- at m/z 564, with the retention time of 
48.3 min. The molecular ion at m/z 564 was increased by 119 Da compared to that of the 
parent compound and there may be cysteine (119Da) reactions occurring at the baicalin 
skeleton. The molecular ion at m/z 564 by loss of the neutral fragment C2O2H3N(60Da) 
produced the product ion at m/z 504 (Fig.10C) in the MS2 spectrum. The obtained ion was 
subjected to MS3 fragmentation, in which the base peak at m/z 389 was observed by the 
losing a glucuronic acid(176 Da). Based on the above results, M3 could be characterized as 
the baicalin cysteine conjugate. 
8. Conclusion 
In this paper, we discribe a strategy using liquid chromatogrphic-electrospray ionization 
(ESI) tandem ion trap mass spectrometric for fast analysis of the metabolic profile of S. 
baicalensis and baicalin. Using negative ion mode and applying the MS fragmentation rules 
of flavonoids reported before, 3 organic components, 9 metabolites in urine, 2 organic and 3 
metabolites in plasma, were identified or tentatively identified in the extracts of S. 
baicalensis. 3 metabolites were identified in bacailin. However, several new analogues were 
identified in the present study, which proved that HPLC-MS is a powerful and rapid 
method to discover new constituents in Chinese medicinal herbs and its metabolites, help to 
lay the foundation of further study in vivo. 
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characteristics of Chinese medicine.
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